647 results on '"El Andaloussi, Samir"'
Search Results
52. An extracellular vesicle delivery platform based on the PTTG1IP protein
53. Correction to: Isolation and Characterization of Extracellular Vesicles from Keratinocyte Cultures
54. Isolation and Characterization of Extracellular Vesicles from Keratinocyte Cultures
55. A CRISPR-Cas9-based reporter system for single-cell detection of extracellular vesicle-mediated functional transfer of RNA
56. The viral protein corona directs viral pathogenesis and amyloid aggregation
57. Identification of Novel Scaffold Proteins for Improved Endogenous Engineering of Extracellular Vesicles
58. Multimodal engineering of extracellular vesicles for efficient intracellular protein delivery
59. Supplementary Figure 2 from Novel Target for Peptide-Based Imaging and Treatment of Brain Tumors
60. Data from Novel Target for Peptide-Based Imaging and Treatment of Brain Tumors
61. Supplementary Figure 1 from Novel Target for Peptide-Based Imaging and Treatment of Brain Tumors
62. Supplementary Methods and Supplementary Figure Legend from Novel Target for Peptide-Based Imaging and Treatment of Brain Tumors
63. Novel endogenous engineering platform for robust loading and delivery of functional mRNA by extracellular vesicles
64. Myeloid cells from Langerhans cell histiocytosis patients exhibit increased vesicle trafficking and an altered secretome capable of activating NK cells
65. Delivery is key: lessons learnt from developing splice‐switching antisense therapies
66. Helicobacter pylori‐derived outer membrane vesicles contribute to Alzheimer's disease pathogenesis via C3‐C3aR signalling
67. The potential role of serum extracellular vesicle derived small RNAs in AML research as non-invasive biomarker
68. Biodistribution of therapeutic extracellular vesicles
69. Chapter 14 - The promise and challenges of extracellular vesicles in the diagnosis of neurodegenerative diseases
70. Chapter 15 - Therapeutic potential of extracellular vesicles in neurodegenerative disorders
71. Single-Stranded Nucleic Acids Regulate TLR3/4/7 Activation through Interference with Clathrin-Mediated Endocytosis
72. Heterogeneity and interplay of the extracellular vesicle small RNA transcriptome and proteome
73. High Soluble Amyloid-β42 Predicts Normal Cognition in Amyloid-Positive Individuals with Alzheimer's Disease-Causing Mutations
74. Exosome-like vesicles released from lipid-induced insulin-resistant muscles modulate gene expression and proliferation of beta recipient cells in mice
75. The Role of N-Acetylcysteine Amide (NACA) As Prophylactic Treatment for Acute Graft-Versus-Host Disease
76. ESDR496 - Comprehensive analysis of extracellular vesicles surface markers produced by normal keratinocytes human cutaneous squamous cell carcinoma cell lines reveals phenotypic heterogeneity
77. SARS-CoV-2 and HSV-1 Induce Amyloid Aggregation in Human CSF
78. Exosomes for targeted siRNA delivery across biological barriers
79. Splice-Correction Strategies for Treatment of X-Linked Agammaglobulinemia
80. Solid formulation of cell-penetrating peptide nanocomplexes with siRNA and their stability in simulated gastric conditions
81. Single particle profiler for measuring properties of nano-sized bioparticles
82. Identification of storage conditions stabilizing extracellular vesicles preparations
83. mRNA-LNP vaccines tuned for systemic immunization induce strong antitumor immunity by engaging splenic immune cells
84. Identification of storage conditions stabilizing extracellular vesicles preparations
85. Insights into the cellular trafficking of splice redirecting oligonucleotides complexed with chemically modified cell-penetrating peptides
86. Exosomes participate in the alteration of muscle homeostasis during lipid-induced insulin resistance in mice
87. Synthetic SiRNA Delivery: Progress and Prospects
88. The potential role of serum extracellular vesicle derived small RNAs in AML research as non-invasive biomarker.
89. Assessing the uptake kinetics and internalization mechanisms of cell-penetrating peptides using a quenched fluorescence assay
90. Optimised Electroporation for Loading of Extracellular Vesicles with Doxorubicin
91. Autologous Peripheral Blood Mononuclear Cells as Treatment in Refractory Acute Respiratory Distress Syndrome
92. Multi-level omics analysis in a murine model of dystrophin loss and therapeutic restoration
93. How much dystrophin is enough: the physiological consequences of different levels of dystrophin in the mdx mouse
94. A stearylated CPP for delivery of splice correcting oligonucleotides using a non-covalent co-incubation strategy
95. Elucidating cell-penetrating peptide mechanisms of action for membrane interaction, cellular uptake, and translocation utilizing the hydrophobic counter-anion pyrenebutyrate
96. The power of imaging to understand extracellular vesicle biology in vivo
97. Growth Media Conditions Influence the Secretion Route and Release Levels of Engineered Extracellular Vesicles
98. Correction to “Delivery of Oligonucleotide Therapeutics: Chemical Modifications, Lipid Nanoparticles, and Extracellular Vesicles”
99. Diagnostic and Prognostic Utility of the Extracellular Vesicles Subpopulations Present in Pleural Effusion
100. Extracellular vesicles are the primary source of blood‐borne tumour‐derived mutant KRAS DNA early in pancreatic cancer
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.